The medical goal is bigger than a number
Short-acting GLP-1 receptor agonists including exenatide immediate-release (Byetta) should be injected within 60 minutes before morning and evening meals , and lixisenatide (Lyxumia) should be administered within 1 hour before any meal of the day
But for over 40% of those on the medication, they also cause a sick-to-the-stomach feeling, aka nausea
While specific market size data for GLP-1 supplements is nascent, growth is undeniable
These symptoms frequently manifest during the initial treatment phase, affecting approximately 50% to 60% of patients [8], but they generally diminish over time, with their occurrence being dose-dependent
Stopping Does Not Mean Failure Weight regain after discontinuation does not necessarily mean the medication failed